Genetic Testing for High-Risk Pancreatic Cancer in Kids

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Recruiting Observational Study
Chronic Pancreatitis Exocrine Pancreas Carcinoma Recurrent Acute Pancreatitis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 17
Sex
Any
Study type
Observational
Participants needed
1,600 (estimated)
Sponsor
M.D. Anderson Cancer Center · Other
Who this trial is looking for

This trial is looking for children under 18 who have had pancreatitis. Participants will provide blood, saliva, urine, or stool samples for genetic testing to help identify mutations that may lead to pancreatic cancer.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am under 18 years old.
  • I have had at least 2 episodes of acute pancreatitis.
  • I have chronic pancreatitis with irreversible changes in my pancreas.
  • I or my parent have signed a consent form for this study.
  • I or my parent have authorized the release of my health information.

You may not be able to join if

  • I have a significant medical illness that can't be controlled.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This clinical trial collects blood, saliva, urine, or stool samples to help identify possible genetic mutations that may increase a person's chance at developing pancreatic cancer. Finding genetic markers among pediatric patients with acute recurrent pancreatitis and chronic pancreatitis may help identify patients who are at risk of pancreatic cancer.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All subjects/parents must sign an informed consent and/or assent indicating that they are aware of the investigational nature of this study * Subjects/parents must have signed an authorization for the release of their or their child's protected health information * All childre…
Contacts

Ying Yuan, PHD

(713) 563-4271

yyuan@mdanderson.org

CONTACT